RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 to support the growth of human leukemic cells in both monolayer and suspension cultures.
RPMI-1640 medium is a versatile solution with numerous applications for various mammalian cell lines, such as Jurkat cells, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.
This formulation includes stable Glutamine and HEPES (25mM).
| Size: | Cat Number: |
|---|---|
| 500 ml | LM-R1638/500 |
Safety Data Sheets are also available in other languages. Please contact us if needed.
Fetal Bovine Serum (FBS) is the liquid part of blood remaining after the removal of the cellular fraction and coagulation factors. It is extracted by…
Pyruvate is the final product of the glycolysis pathway, where glucose is converted into pyruvate with the production of ATP. Sodium pyruvate at 100mM (11g/L)…
Trypsin, an enzyme derived from the porcine pancreas, is commonly used to dissociate mammalian cells and tissues. The concentration of trypsin required to detach cells…
